Daily funding roundup - March 28th, 2019

BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M

Artiphon: Artiphon is empowering a new generation to explore music-making with smart instruments and adaptive software. Artiphon has raised $2 million in seed funding led by Warner Music Group. Read more

Biolinq: Biolinq develops skin-applied electronic sensors. Biolinq has raised $4.75 million from JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Read more  

Spike: Spike delivers original entertainment that informs, engages, inspires and above all push the boundaries. Spike has raised $5 million from Wix, Koa Labs, and NFX. Read more

BillionToOne: BillionToOne's mission is to make prenatal testing safe and affordable for every expecting mother. BillionToOne has raised $15 Million Series A funding co-led by Hummingbird and NeoTribe. Read more

CB4: CB4 provides a patented software solution for brick and mortar retail companies. CB4  has raised $16 million in Series B funding led byOctopus Ventures, with participation from Sonae IM and earlier backers Sequoia Capital and Pereg Ventures. Read more

Polyneuron Pharmaceuticals: Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases of the nervous system where a pathological role of anti-carbohydrate autoantibodies is well established. Polyneuron as raised $22.6 million in Series A funding co-led by Sofinnova Partners and NEA. Read more

ATAI Life Sciences: ATAI is an internationally active biotech company investing in and acquiring therapeutics focusing on longevity and mental wellbeing. ATAI has raised $43 million in Series B funding. Subversive Capital led the round. Other participants include Apeiron Investment Group, Bail Capital, a private equity firm; and Efrem Kamen, founder of the health care fund Pura Vida Investments. Read more   

Kong: Kong is a provider of application programming interface management for companies. Kong has raised $43 million in Series C funding led by Index Ventures. Other participants in the round include earlier backers Andreessen Horowitz and CRV, and new investors GGV Capital andWorld Innovation Lab. Read more

Prevail Therapeutics: Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases. Prevail Therapeutics has raised $50 million in Series B funding. Investors include Surveyor Capital and AbbVie, along with earlier backers OrbiMed, Pontifax, RA Capital Management, Adage Capital, Boxer Capital, EcoR1 Capital, Omega Funds, BVF Partners and Alexandria Venture Investments. Read more

Inivata: Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis. Inivata has raised $52.6 million in Series B funding. Earlier backers Woodford Patient Capital Trust, IP Group, Cambridge Innovation Capital and Johnson & Johnson Innovation all participated in the round, along with new investor RT Ventures. Read more

PayIt: PayIt simplifies doing business with state, local and federal government through its mobile transaction and payment platform. PayIt has raised $100 million from Insight Partners. Read more

Kyriba: Kyriba offers SaaS-based treasury solutions that enable treasury departments to plan for market volatility, regulation, and opportunities. Kyriba has raised $160 million at a $1.2 billion valuation from the private equity firm Bridgepoint in exchange for majority ownership in the company. Read more

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple of days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile.